Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Inorganic Chemistry|April 16, 2002
Mononuclear and mixed-valence binuclear oxovanadium complexes with benzimidazole-derived chelating agentsShyamali Ghosh, Kausik K Nanda, Anthony W Addison, et al.Gene|November 6, 2004
Multiple novel transcription initiation sites for NRG1Valgerdur Steinthorsdottir, Hreinn Stefansson, Shyamali Ghosh, et al.Journal of Molecular Evolution|June 27, 2007
A statistical approach to identify ancient template DNAAgnar Helgason, Snaebjörn Pálsson, Carles Lalueza-Fox, et al.Plos Genetics|January 17, 2009
Sequences from first settlers reveal rapid evolution in Icelandic mtDNA poolAgnar Helgason, Carles Lalueza-Fox, Shyamali Ghosh, et al.Journal of Medicinal Chemistry|September 8, 2009
Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunitsEdward C Lawson, Diane K Luci, Shyamali Ghosh, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessmentDiane K Luci, Shyamali Ghosh, Charles E Smith, et al.The Journal of Organic Chemistry|February 19, 2008
Suzuki-Miyaura approach to JNJ-26076713, an orally active tetrahydroquinoline-containing alphaVbeta3/alphaVbeta5 integrin antagonist. enantioselective synthesis and stereochemical studiesWilliam A Kinney, Christopher A Teleha, Andrew S Thompson, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrinsBart L De Corte, William A Kinney, Li Liu, et al.The Journal of Pharmacology and Experimental Therapeutics|December 18, 2007
Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic ratsRosemary J Santulli, William A Kinney, Shyamali Ghosh, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2004
1,2,3,4-Tetrahydroquinoline-containing alphaVbeta3 integrin antagonists with enhanced oral bioavailabilityShyamali Ghosh, Rosemary J Santulli, William A Kinney, et al.Pageof 2